Siga Technologies: Market Awaits MPOXX Purchases, Investor Remains On Sidelines

lunes, 1 de diciembre de 2025, 6:25 pm ET1 min de lectura
SIGA--

The article discusses SIGA Technologies, a biotech company focused on developing medical countermeasures for bioterrorism agents. The author, a finance expert, remains on the sidelines as the market waits for the company to complete MPOXX purchases. The author notes that SIGA's previous notes on the company were published in June and December 2024.

Siga Technologies: Market Awaits MPOXX Purchases, Investor Remains On Sidelines

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios